Publications by authors named "Yukiko Inada"

Claim this Profile
C
Cause-specific mortality following sustained virologic response in hepatitis C patients treated with direct-acting antivirals: a standardized mortality ratio analysis.
Seiichi Mawatari, Shiroh Tanoue, Kotaro Kumagai, Kohei Oda, Ai Toyodome, Yukiko Inada

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus.
Seiichi Mawatari, Kotaro Kumagai, Kohei Oda, Kazuaki Tabu, Sho Ijuin, Yukiko Inada

PLoS One· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypovascular tumors developed into hepatocellular carcinoma at a high rate despite the elimination of hepatitis C virus by direct-acting antivirals.
Kazuaki Tabu, Seiichi Mawatari, Kohei Oda, Kotaro Kumagai, Yukiko Inada

PLoS One· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Transient Pancreatitis Associated With Milk Allergy in an Infant.
Yukiko Inada, Takuji Nakamura, Masafumi Zaitsu

Indian Pediatr· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral and host factors are associated with retreatment failure in hepatitis C patients receiving all-oral direct antiviral therapy.
Seiichi Mawatari, Kohei Oda, Kotaro Kumagai, Kazuaki Tabu, Sho Ijuin, Yukiko Inada

Hepatol Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of tolvaptan on the prognosis of patients with hepatic ascites.
Yasunari Hiramine, Hirofumi Uto, Seiichi Mawatari, Shuji Kanmura, Yasushi Imamura, Yukiko Inada

Hepatol Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir.
Seiichi Mawatari, Kohei Oda, Kazuaki Tabu, Sho Ijuin, Kotaro Kumagai, Yukiko Inada

PLoS One· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.
Norio Akuta, Joji Toyota, Yoshiyasu Karino, Fusao Ikeda, Akio Ido, Yukiko Inada

J Gastroenterol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New resistance-associated substitutions and failure of dual oral therapy with daclatasvir and asunaprevir.
Seiichi Mawatari, Kohei Oda, Kazuaki Tabu, Sho Ijuin, Kotaro Kumagai, Yukiko Inada

J Gastroenterol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection.
Joji Toyota, Yoshiyasu Karino, Fumitaka Suzuki, Fusao Ikeda, Akio Ido, Yukiko Inada

J Gastroenterol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3.
Graham R Foster, Kazuaki Chayama, Wan-Long Chuang, Hugo Fainboim, Martti Farkkila, Yukiko Inada

Springerplus· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute alcohol intoxication in a 15-day-old neonate.
Masafumi Zaitsu, Yukiko Inada, Katsuya Tashiro, Chiduru Hayashi, Hirohito Doi

Pediatr Int· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced CCL26 production by IL-4 through IFN-gamma-induced upregulation of type 1 IL-4 receptor in keratinocytes.
Natsuko Nishi, Shuichi Yamamoto, Weilin Ou, Eriko Muro, Yukiko Inada

Biochem Biophys Res Commun· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis